Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
HuL-001 in Idiopathic Pulmonary Fibrosis: NCT04540770 Clinical Landscape Report 2026
16 October 2026
NCT04540770 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Marzeptacog alfa in Hemorrhage: NCT04548791 Clinical Landscape Report 2026
16 October 2026
NCT04548791 clinical landscape for Hemorrhage: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Emicizumab in Hemophilia A: NCT04563520 Clinical Landscape Report 2026
16 October 2026
NCT04563520 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SIG-001 in Hemophilia A: NCT04541628 Clinical Landscape Report 2026
16 October 2026
NCT04541628 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zinpentraxin alfa in Idiopathic Pulmonary Fibrosis: NCT04552899 Clinical Landscape Report 2026
16 October 2026
NCT04552899 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Narmafotinib in Idiopathic Pulmonary Fibrosis: ACTRN12620000894998 Clinical Landscape Report 2026
16 October 2026
ACTRN12620000894998 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Octocog alfa(Bayer AG) in Hemophilia A: NCT04565236 Clinical Landscape Report 2026
16 October 2026
NCT04565236 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Emicizumab in Hemophilia A: NCT04567511 Clinical Landscape Report 2026
16 October 2026
NCT04567511 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Susoctocog alfa in Hemorrhage: NCT04580407 Clinical Landscape Report 2026
16 October 2026
NCT04580407 clinical landscape for Hemorrhage: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Voxelotor in Hemoglobin SC Disease: NL-OMON26164 Clinical Landscape Report 2026
16 October 2026
NL-OMON26164 clinical landscape for Hemoglobin SC Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Voxelotor in Anemia, Sickle Cell: NCT04581356 Clinical Landscape Report 2026
16 October 2026
NCT04581356 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Recombinant Human Coagulation Factor VIII Liposomal(Ascension Healthcare) in Hemophilia A: NCT04592692 Clinical Landscape Report 2026
16 October 2026
NCT04592692 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.